Oncology corporate

21 – 30 of 37

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001382?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2023
Mark Exploring new prognostic biomarkers in Mantle Cell Lymphoma : a comparison of the circSCORE and the MCL35 score
Salim, Ruth ; Husby, Simon ; Winther Eskelund, Christian ; Scott, David W. ; Holte, Harald ; Kolstad, Arne ; Räty, Riikka ; Ek, Sara ^LU ; Jerkeman, Mats ^LU and Geisler, Christian , et al. (2023) In Leukemia and Lymphoma 64(8). p.1414-1423
- Contribution to journal › Article
Mark Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
Nikkarinen, Anna ; Lokhande, Lavanya ^LU ; Amini, Rose Marie ; Jerkeman, Mats ^LU ; Porwit, Anna ^LU ; Molin, Daniel ; Enblad, Gunilla ; Kolstad, Arne ; Räty, Riikka and Hutchings, Martin , et al. (2023) In Blood Advances 7(18). p.5304-5313
- Contribution to journal › Article
Mark Secondary malignancies among mantle cell lymphoma patients
Abalo, Kossi D. ; Smedby, Karin E. ; Ekberg, Sara ^LU ; Eloranta, Sandra ; Pahnke, Simon ; Albertsson-Lindblad, Alexandra ^LU ; Jerkeman, Mats ^LU and Glimelius, Ingrid (2023) In European Journal of Cancer 195.
- Contribution to journal › Article
Mark Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation
Ekberg, Sara ; Smedby, Karin E. ; Albertsson-Lindblad, Alexandra ^LU ; Jerkeman, Mats ^LU ; Weibull, Caroline E. and Glimelius, Ingrid (2023) In Blood Advances 7(5). p.866-874
- Contribution to journal › Article
2022
Mark Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
Wang, Michael L. ; Jurczak, Wojciech ; Jerkeman, Mats ^LU ; Trotman, Judith ; Zinzani, Pier L. ; Belada, David ; Boccomini, Carola ; Flinn, Ian W. ; Giri, Pratyush and Goy, Andre , et al. (2022) In New England Journal of Medicine 386(26). p.2482-2494
- Contribution to journal › Article
Mark Evalutation of two commercial deep learning OAR segmentation models for prostate cancer treatment
Gorgisyan, Jenny ^LU ; Bengtsson, Ida ; Lempart, Michael ^LU ; Lerner, Minna ^LU ; Wieslander, Elinore ^LU ; Alkner, Sara ^LU and Jamtheim Gustafsson, Christian ^LU (2022) ESTRO 2022
- Contribution to conference › Abstract
Mark Tackling Mantle Cell Lymphoma in Europe
Horgan, Denis ; Walewski, Jan ; Aurer, Igor ; Visco, Carlo ; Giné, Eva ; Fetica, Bogdan ; Jerkeman, Mats ^LU ; Kozaric, Marta ; da Silva, Maria Gomes and Dreyling, Martin (2022) In Healthcare (Switzerland) 10(9).
- Contribution to journal › Article
Mark High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis
Kolijn, P. Martijn ; Hosnijeh, Fatemeh Saberi ; Späth, Florentin ; Hengeveld, Paul J. ; Agathangelidis, Andreas ; Saleh, Manal ; Casabonne, Delphine ; Benavente, Yolanda ; Jerkeman, Mats ^LU and Agudo, Antonio , et al. (2022) In Blood 139(10). p.1557-1563
- Contribution to journal › Article
Mark Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
Merrien, Magali ; Wasik, Agata M. ; Ljung, Elin ; Morsy, Mohammad H.A. ; de Matos Rodrigues, Joana ^LU ; Carlsten, Mattias ; Rassidakis, Georgios Z. ; Christensson, Birger ; Kolstad, Arne and Jerkeman, Mats ^LU , et al. (2022) In Virchows Archiv 480(3). p.655-666
- Contribution to journal › Article
Mark Idelalisib in relapsed/refractory diffuse large B-cell lymphoma : results from a Nordic Lymphoma Group phase II trial
Fjordén, Karin ^LU ; Ekberg, Sara ; Kuric, Nevzeta ; Smedby, Karin E. ; Lagerlöf, Ingemar ; Larsen, Thomas S. ; Jørgensen, Judit M. ; de Nully Brown, Peter and Jerkeman, Mats ^LU (2022) In British Journal of Haematology 196(2). p.437-440
- Contribution to journal › Letter